1. What are the Real Lessons from Vioxx®?

   • I. Ralph Edwards

   Editorial 20 November 2012 Pages: 651 - 658

2. The Effect of HMG-CoA Reductase Inhibitors on Coenzyme Q₁₀

   • Iain P. Hargreaves
   • Andrew J. Duncan
   • John M. Land

   Leading Article 20 November 2012 Pages: 659 - 676

   

3. Undesirable Effects of Citrus Juice on the Pharmacokinetics of Drugs

   • Mitsuo Saito
   • Mutsuko Hirata-Koizumi
   • Ryuichi Hasegawa

   Review Article 20 November 2012 Pages: 677 - 694

   

4. Treating Mood Disorders During Pregnancy

   • Malin Eberhard-Gran
   • Anne Eskild
   • Stein Opjordsmoen

   Review Article 20 November 2012 Pages: 695 - 706

   

5. Fetal Safety of Drugs Used in the Treatment of Allergic Rhinitis

   • Cameron Gilbert
   • Paolo Mazzotta
   • Gideon Koren

   Review Article 20 November 2012 Pages: 707 - 719

   

6. Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis

   • Ann Cranney
   • Jonathan D. Adachi

   Review Article 20 November 2012 Pages: 721 - 730

   

7. Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986—2001)

   • Frantz Thiessard
   • Emmanuel Roux
   • Bernard Bégaud

   Original Research Article 20 November 2012 Pages: 731 - 740

   

8. Tolerability of Treatments for Postherpetic Neuralgia

   • Nancy A. Alvarez

   Correpondence 20 November 2012 Pages: 741 - 741

9. The Authors’ Reply

   • Robert W. Johnson
   • Anthony L. Cunningham

   Correspondence 20 November 2012 Pages: 742 - 742